| scholarly article | Q13442814 |
| P2093 | author name string | Marie-Claire Maroun | |
| Félix Fernández Madrid | |||
| P2860 | cites work | The 56K autoantigen is identical to human annexin XI | Q24305066 |
| The primary structure of the 32-kDa subunit of human replication protein A | Q24337175 | ||
| Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome | Q24558767 | ||
| Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis | Q24561466 | ||
| Human neoplasms elicit multiple specific immune responses in the autologous host | Q24564371 | ||
| Inflammation and cancer | Q24649640 | ||
| Cancer-related inflammation | Q27860907 | ||
| A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 | ||
| Multi-analyte immunoassay | Q28241097 | ||
| Reduced lung-cancer mortality with low-dose computed tomographic screening | Q28241954 | ||
| Genetic control of autoimmunity in type 1 diabetes | Q28246567 | ||
| Detection of anti-nuclear antibodies from patients with systemic rheumatic diseases by ELISA using HEp-2 cell nuclei | Q28267160 | ||
| Ligand assays: from electrophoresis to miniaturized microarrays | Q28281892 | ||
| Cancer. p53, guardian of the genome | Q29615610 | ||
| Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology | Q29618865 | ||
| Stromal fibroblasts in cancer initiation and progression | Q29618873 | ||
| Molecular cloning of human apolipoprotein B cDNA. | Q30406574 | ||
| Proteomics: a technology-driven and technology-limited discovery science | Q30668652 | ||
| Profiling tumor-associated antibodies for early detection of non-small cell lung cancer | Q30830942 | ||
| Protein arrays for gene expression and molecular interaction screening | Q30878625 | ||
| Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer | Q31042618 | ||
| Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA). | Q33185563 | ||
| Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer | Q33205409 | ||
| Improved approach to identify cancer-associated autoantigens | Q33215080 | ||
| Autoantibody signatures in prostate cancer | Q33223730 | ||
| Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis | Q33227518 | ||
| Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. | Q33232102 | ||
| Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients | Q33239982 | ||
| Autoantibody approach for serum-based detection of head and neck cancer. | Q33305783 | ||
| Defining the role of the MHC in autoimmunity: a review and pooled analysis | Q33330857 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Positive antinuclear antibodies in malignancies | Q33564636 | ||
| UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions | Q33613520 | ||
| p53 Antibodies in the sera of patients with various types of cancer: a review | Q33892337 | ||
| An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer | Q33933918 | ||
| Antinuclear antibody testing | Q34140585 | ||
| Type I diabetes mellitus. A chronic autoimmune disease | Q34181699 | ||
| Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies | Q34219323 | ||
| Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus | Q34253174 | ||
| Presence of antibodies to different subunits of replication protein A in autoimmune sera | Q34290778 | ||
| Autoantibodies in the diagnosis of systemicrheumatic diseases | Q34299389 | ||
| Cancer stem cells: an old idea--a paradigm shift | Q34495973 | ||
| Clinical validation of an autoantibody test for lung cancer | Q34537374 | ||
| Immunofluorescence versus ELISA for the detection of antinuclear antigens | Q34671936 | ||
| Disease proteomics | Q35084579 | ||
| Risk factors for ANA positivity in healthy persons | Q35092882 | ||
| Role of tissue stroma in cancer cell invasion | Q35170428 | ||
| Naturally occurring B-cell responses to breast cancer | Q35200581 | ||
| Relative paradigms between autoantibodies in lupus and autoantibodies in cancer | Q35583352 | ||
| Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies | Q35831220 | ||
| The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination | Q35848418 | ||
| Cytokines in cancer immunity and immunotherapy | Q35951855 | ||
| Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy | Q36081533 | ||
| Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis | Q36169087 | ||
| Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer | Q36292740 | ||
| Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression | Q36393268 | ||
| Sex hormones and the genesis of autoimmunity | Q36426551 | ||
| Sexual dimorphism in innate immune responses to infectious organisms | Q36557755 | ||
| Use of autoantibodies in breast cancer screening and diagnosis. | Q36573831 | ||
| Cytokines in breast cancer. | Q36576294 | ||
| Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer | Q36617301 | ||
| Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study | Q36618943 | ||
| The clinical significance of autoantibodies in gastrointestinal malignancies: an overview | Q36764924 | ||
| Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. | Q46821034 | ||
| Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes | Q47594222 | ||
| Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes | Q47669219 | ||
| Determination of autoantibodies to annexin XI in systemic autoimmune diseases | Q50118870 | ||
| Smooth muscle antibody in malignant disease | Q50276605 | ||
| Anticardiolipin antibodies in acute myeloid leukemia: prevalence and clinical significance. | Q50908754 | ||
| Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. | Q53522277 | ||
| Multiple sclerosis: light at the end of the tunnel. | Q54431373 | ||
| Autoantibodies to c-myc nuclear protein products in autoimmune disease. | Q54719717 | ||
| Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells | Q56895631 | ||
| Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis | Q57351990 | ||
| Heat inactivation of Ku autoantigen: possible role in hyperthermic radiosensitization | Q64389204 | ||
| Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis | Q66880774 | ||
| Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study | Q67724726 | ||
| Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients | Q68421878 | ||
| Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis | Q68556874 | ||
| The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies | Q68800319 | ||
| Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma | Q68928820 | ||
| The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies | Q69737025 | ||
| Characterization of the interaction of aminoacyltransferase II with ribosomes. Binding of transferase II and translocation of peptidyl transfer ribonucleic acid | Q69863829 | ||
| Detection of anti-histone activity in sera of patients with monoclonal gammopathies | Q70320577 | ||
| Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells | Q70535330 | ||
| Gender-related influences on the development of chronic graft-versus-host disease-induced experimental lupus nephritis | Q70587002 | ||
| Autoimmunity to collagen in human lung cancer | Q70866366 | ||
| Serum p53 antibodies as early markers of lung cancer | Q71803498 | ||
| Translocase activity in the aminoacyl transferase II fraction from rat liver | Q72146960 | ||
| Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases | Q73343818 | ||
| p53 serum antibodies as prognostic indicator in head and neck cancer | Q73401647 | ||
| Cross-reaction of lupus anti-dsDNA antibodies with protein translation factor EF-2 | Q73404132 | ||
| The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma | Q73505457 | ||
| Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas | Q73537019 | ||
| Autoantibodies to p53 in sera of patients with autoimmune thyroid disease | Q73781313 | ||
| Anticardiolipin and antinuclear antibodies in cancer patients--a case control study | Q73795696 | ||
| Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein | Q73886871 | ||
| Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women | Q74144040 | ||
| Serum anti-p53 autoantibodies in patients with type 1 diabetes | Q74385882 | ||
| Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma | Q74451695 | ||
| Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus | Q76395333 | ||
| Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus | Q79171865 | ||
| Malignancies and autoimmune rheumatic diseases | Q79235177 | ||
| Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours | Q83172475 | ||
| Lung adenocarcinoma and antiphospholipid antibodies | Q83277719 | ||
| Harnessing the immune response for cancer detection | Q83758329 | ||
| High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma | Q83834740 | ||
| Antinuclear antibodies in patients with malignancies | Q93726966 | ||
| Polarized immune responses differentially regulate cancer development | Q36808629 | ||
| Antiphospholipid antibody syndrome and autoimmune diseases | Q37061147 | ||
| Antiphospholipid antibodies, antiphospholipid syndrome and infections | Q37092997 | ||
| Rheumatic disorders as paraneoplastic syndromes | Q37166826 | ||
| A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth | Q37353341 | ||
| Definition of human autoimmunity--autoantibodies versus autoimmune disease | Q37645008 | ||
| Malignancies in autoimmune rheumatic diseases - a mini-review | Q37746748 | ||
| Anti-Ku antibodies: Clinical, genetic and diagnostic insights | Q37771746 | ||
| The X chromosome in immune functions: when a chromosome makes the difference | Q37774853 | ||
| Solid cancer, antiphospholipid antibodies, and venous thromboembolism | Q37801034 | ||
| On the frontline of screening for breast cancer | Q37848522 | ||
| Lymphokines | Q38178601 | ||
| Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and sjögren's syndrome: An interlaboratory collaboration | Q39669572 | ||
| Autoimmunity and malignancy | Q39823089 | ||
| Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens | Q40266575 | ||
| A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups | Q40743626 | ||
| Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer | Q40770750 | ||
| Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. | Q40811485 | ||
| Humoral immunity in polymyositis/dermatomyositis | Q40870512 | ||
| Antinuclear antibodies as potential markers of lung cancer. | Q40944858 | ||
| Antibodies to type II collagen in relapsing polychondritis | Q41043794 | ||
| Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome | Q41089131 | ||
| The association of malignancy with rheumatic and connective tissue diseases | Q41519028 | ||
| Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation | Q41612390 | ||
| Apoptosis by p53: mechanisms, regulation, and clinical implications | Q41737530 | ||
| Clinical application of a test for lupus globulin-nucleohistone interaction using fluorescent antibody | Q41838818 | ||
| Loss of annexin II heavy and light chains in prostate cancer and its precursors. | Q42509213 | ||
| Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg? | Q42790883 | ||
| A calcyclin-associated protein is a newly identified member of the Ca2+/phospholipid-binding proteins, annexin family | Q43632651 | ||
| The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist | Q44088706 | ||
| Benign and malignant lymphoid proliferation in autoimmunity | Q44177094 | ||
| Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer | Q45263174 | ||
| De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent | Q46068963 | ||
| Recursive partitioning as an approach to selection of immune markers for tumor diagnosis | Q46135231 | ||
| Autoantigen microarrays for multiplex characterization of autoantibody responses | Q46316594 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 507-525 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Rheumatic Diseases Clinics of North America | Q7320483 |
| P1476 | title | Serologic laboratory findings in malignancy | |
| P478 | volume | 37 |
| Q33895872 | Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis |
| Q26999045 | CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases |
| Q38578005 | Cripto-1: an extracellular protein - connecting the sequestered biological dots |
| Q35134650 | Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer |
| Q35161069 | Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer |
| Q35544786 | Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients |
| Q31109622 | Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China |
| Q52353641 | Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas. |
| Q64972429 | The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be. |
| Q38758065 | Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer |
Search more.